---
layout: post
title: "Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals Research and Development"
date: 2026-02-05 18:58:58 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-09061
original_published: 2022-04-28 00:00:00 +0000
significance: 8.00
---

# Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals Research and Development

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 28, 2022 00:00 UTC
**Document Number:** 2022-09061

## Summary

Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/28/2022-09061/importer-of-controlled-substances-application-royal-emerald-pharmaceuticals-research-and-development)
- API: https://www.federalregister.gov/api/v1/documents/2022-09061

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
